UBS OCONNOR LLC - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 62 filers reported holding RAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$592,939
-100.0%
67,842
-79.2%
0.02%
-40.0%
Q3 2022$1,593,000,000
-14.0%
326,451
-2.0%
0.03%
+11.1%
Q2 2022$1,853,000,000333,2510.03%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,571,379$7,967,0002.01%
Cormorant Asset Management, LP 2,326,660$11,796,0000.91%
BVF INC/IL 3,526,729$17,881,0000.72%
Boxer Capital, LLC 1,175,000$5,957,0000.31%
Perceptive Advisors 2,483,619$12,592,0000.25%
Logos Global Management LP 134,194$680,0000.09%
Lumina Fund Management LLC 6,000$30,0000.01%
Woodline Partners LP 119,700$607,0000.01%
Trexquant Investment LP 28,373$144,0000.01%
Alyeska Investment Group, L.P. 125,000$634,0000.01%
View complete list of RAIN THERAPEUTICS INC shareholders